This study will assess the feasibility of implementing HPV self-sampling as a primary cervical cancer screening strategy for under-screened women in the emergency department (ED). Eligible participants will receive education and an HPV self-sampling kit to complete in the ED. Individuals with HPV-positive results will be guided to follow-up care at a local clinic.
The proposed study will implement HPV self-sampling as primary cervical screening for under-screened ED patients. The long-term goal is to increase access to cervical screening for women who may not routinely use primary care and thus face increased risk of cervical cancer. This pilot feasibility trial will implement HPV self-sampling kit distribution and navigation to follow-up care in the ED. The investigators hypothesize that ED-based in-person distribution and same-day return of HPV self-sampling kits will alleviate issues of prior mailed HPV self-sampling trials by reducing participant burden. Women (30-65 years with non-critically ill presentations) who present to the ED and are overdue for cervical screening will receive 1) cervical cancer screening education and 2) a HPV self-sampling kit where they return the kit immediately after self-sampling in the ED. ScreenNJ will navigate participants with HPV-positive results to follow-up care and management according to current standard guidelines at local clinics.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SCREENING
Masking
NONE
Enrollment
100
Participants will be asked to collect a vaginal sample for HPV screening.
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
University Hospital
Newark, New Jersey, United States
Completion of ED-Based HPV Self-Sampling
Evaluate the proportion of eligible participants who complete HPV self-sampling during the emergency department visit.
Time frame: Day 1
HPV Self Sampling Acceptability
Acceptability of Intervention Measure (AIM) scale (Weiner et al., 2017). Scale values range from 1 to 5, where higher is more acceptable.
Time frame: After results notification, an average of 1 week
HPV Self Sampling Feasibility
Feasibility of Intervention Measure (FIM) scale (Weiner et al., 2017). Scale values range from 1 to 5, where higher is more feasible.
Time frame: After results notification, an average of 1 week
HPV Knowledge
Cervical Cancer Knowledge Scale (CCKS)- 7 items where a higher score is more knowledge
Time frame: Day 1 and after results notification- an average of 1 week
Screening Completion
Proportion of HPV+ women who complete follow-up screening
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.